Elanco Animal Health (ELAN) P/S ratio

P/S ratio today
2.7×

Elanco Animal Health (ELAN) trades at 2.7× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 2.4×. That is 75.6% higher than the 1.4× of fiscal 2024. Figures as of 18 Nov 2026, 09:28 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/S ratio today
2.7×
P/S ratio, fiscal 2025
2.4×
Change on fiscal 2024
+75.6%
Highest on record
4.1×fiscal 2020
Lowest on record
1.4×fiscal 2022
Fiscal years on record
82018–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Elanco Animal Health P/S ratio, in more detail

Today's figure is 14.2% above the fiscal 2025 year-end.

Across the 8 fiscal year-ends on record (2018–2025), the highest was 4.1× in fiscal 2020 and the lowest 1.4× in fiscal 2022. Today's P/S ratio is higher than at 50% of the 8 fiscal year-ends on record; their median is 2.6×.

History · 8 fiscal years

P/S ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Elanco Animal Health P/S ratio, year by year

Elanco Animal Health (ELAN) P/S ratio by fiscal year
Fiscal yearP/S ratioChangeYear endedShare price at year-endRevenue per share
Today2.7×—$25.85—
20252.4× 75.6% up$22.63$9.50
20241.4× 18.3% down$12.11$8.93
20231.7× 22.8% up$14.90$8.97
20221.4× 53.4% down$12.22$9.03
20212.9× 29.8% down$28.38$9.78
20204.1× 16.5% up$30.67$7.42
20193.6× 10.1% up$29.45$8.29
20183.2×—$31.53$9.78
2017———$9.85
2016———$9.93

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end.

How to read it

It prices each unit of sales and still works when there is no profit; what counts as high depends on the margin those sales earn.

P/S ratio at health care companies of similar size

P/S ratio of Elanco Animal Health and comparable companies
CompanyP/S ratio
Glaukos GKOS28.4×
Encompass Health EHC2.3×
BrightSpring Health Services BTSG1.1×
Baxter International BAX1.2×
Elanco Animal Health ELAN2.7×
Smith & Nephew SNN2.1×

Today's market value divided by revenue for the latest fiscal year. A company whose statements are in another currency than its shares is left out.

More on ELAN

Elanco Animal Health, figure by figure

Elanco Animal Health (ELAN) overview: price, valuation and scorecardAll health care companies by market value

Elanco Animal Health P/S ratio: questions and answers

What is Elanco Animal Health's P/S ratio?

Elanco Animal Health (ELAN) trades at 2.7× its revenue per share for fiscal 2025. At the end of fiscal 2025 (December 31, 2025) its P/S ratio was 2.4×. That is 75.6% higher than the 1.4× of fiscal 2024.

Is Elanco Animal Health's P/S ratio high or low compared with its own history?

Today's P/S ratio is higher than at 50% of the 8 fiscal year-ends on record; their median is 2.6×.

What are the highest and lowest P/S ratio figures on record for Elanco Animal Health?

Across the 8 fiscal year-ends on record (2018–2025), the highest was 4.1× in fiscal 2020 and the lowest 1.4× in fiscal 2022.

How is Elanco Animal Health's P/S ratio calculated?

The P/S ratio is the share price divided by revenue per share — the same thing as market value divided by revenue — taken at each fiscal year-end. For Elanco Animal Health it is on record here for 8 fiscal years, 2018 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Elanco Animal Health (ELAN) P/S ratio”, data as of 18 November 2026. https://funkfolio.com/stock/ELAN/ps-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.